Factbox-Corporate America weighs business impact of new weight-loss drugs

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 52 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 63%

Ireland News News

Ireland Ireland Latest News,Ireland Ireland Headlines

Explore stories from Atlantic Canada.

Celebrating Wild Caraway: Taste of Nova Scotia's Restaurant of the Year | SaltWire - U.S. companies across sectors such as food and beverage makers and manufacturers of glucose monitors are facing investor questions over the risk to future sales from the growing popularity of promising weight-loss treatments.

Mounjaro, which uses the same active ingredient, was approved for diabetes patients last year, but some consumers were using it off-label for weight loss.Conagra might consider changing portion sizes of its snacks if the rising use of weight-loss drugs leads to a change in food consumption patterns. Coca-Cola CEO James Quincey said the company was monitoring what impact, if any weight-loss drugs will have.

Davita is closely monitoring developments related to the drug and expects limited impact from use of the drugs, since they may only benefit some kidney disease patients.Johnson & Johnson's third-quarter sales for devices used in abdomen surgeries was hit by a slowdown in demand for weight-loss and other procedures, as many obese patients turned to Wegovy and Ozempic.

Abbott CEO Robert Ford has said diabetes patients could end up using glucose monitors with the weight-loss drugs in the long term. Dexcom, which also makes such monitors, said something similar in late October.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 45. in İE

Ireland Ireland Latest News, Ireland Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Factbox-Corporate America weighs business impact of new weight-loss drugsDrugs in a class known as GLP-1 such as Novo Nordisk's Wegovy and Ozempic as well as Eli Lilly's Mounjaro have been shown to help control blood sugar and...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Factbox-How Huawei plans to rival Nvidia in the AI chip businessU.S. curbs on the sales of advanced artificial chips by Nvidia to China are creating an opening for Huawei to win market share, with sources saying it won a ...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »